secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2024-04-15T23:59:59+00:00
Accession:  0001493152-24-014611
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------------

- Nasdaq letter on April 10, 2024: common stock failed $1.00 minimum bid for 30 consecutive business days.
- Compliance period of 180 calendar days until October 7, 2024 to regain listing requirement.
- To cure, closing bid price must be $1.00 or more for at least 10 consecutive business days.
- If not cured, may be eligible for additional 180-day period if other listing standards are met.
- No immediate impact on trading; common stock continues to trade on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224014611/0001493152-24-014611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224014611/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-014611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer